Orlando, Fla.—Average-risk breast cancer patients are so unlikely to gain any survival benefit from contralateral prophylactic mastectomy that the 2016 consensus statement issued by the American Society of Breast Surgeons (ASBrS) urges physicians to discourage CPM in those patients.
“This is the strongest language to date used by a society,” said Todd Tuttle, MD, MS, a professor of surgery and the chief of surgical oncology at the University of Minnesota, in